Effect of phosphate transporter and methylation inhibitor drugs on the disposition of arsenate and arsenite in rats

被引:35
作者
Csanaky, I [1 ]
Gregus, Z [1 ]
机构
[1] Univ Pecs, Sch Med, Dept Pharmacol & Pharmacotherapy, H-7643 Pecs, Hungary
关键词
arsenic; monomethylarsonous acid; foscarnet (fos-fonoformic acid); fosfomycin; entacapone; nitrous oxide (N2O); methylation; catechol-O-methyltransferase (COMT); methylcobalamin; biliary excretion; urinary excretion;
D O I
10.1093/toxsci/63.1.29
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Arsenate (AsV) is biotransformed into the more toxic arsenite (AsIII) and monomethylarsonous acid (MMAsIII), but it is unknown how to decrease production of these harmful metabolites. We investigated the effects of foscarnet and fosfomycin, drugs interacting with the phosphate transporter, on biotransformation of AsV, an analog of inorganic phosphate. The effects of entacapone, an inhibitor of catechol-O-methyl transferase (COMT), and nitrous oxide, an inactivator of methylcobalamin, were also tested on the formation of MMAsIII from AsIII in order to clarify the role of COMT and methylcobalamin in biomethylation of AsIII. Arsenic in bile and urine of control and treated rats receiving AsV or AsIII was speciated by HPLC-HG-AFS. In AsV-injected rats, foscarnet, but not fosfomycin, increased the urinary excretion of AsV and decreased the biliary and urinary excretion of AsIII as well as biliary excretion of MMAsIII. In AsIII-injected rats, however, foscarnet failed to influence the excretion of AsIII and its metabolites, suggesting that this drug inhibits the hepatic uptake and renal reabsorption of AsV, thereby decreasing formation of AsIII and MMAsIII from AsV. Entacapone or nitrous oxide pretreatment slightly or not at all influenced the biliary excretion of MMAsIII and urinary excretion of dimethylarsinic acid (DMAsV) in AsIII-injected rats. In contrast, periodate-oxidized adenosine, an inhibitor of S-adenosylmethionine-dependent methyltransferases, nearly abolished appearance of methylated arsenic metabolites in bile and urine. Thus, foscarnet facilitates urinary clearance of AsV and decreases formation of toxic AsIII and MMAsIII, indicating that this drug may be used to promote elimination and counter toxification of AsV. Because entacapone and nitrous oxide influenced the excretion of MMAsIII and DMAsV negligibly, neither COMT nor methylcobalamin appears to be involved in arsenic methylation in rats.
引用
收藏
页码:29 / 36
页数:8
相关论文
共 51 条
[1]   Occurrence of monomethylarsonous acid in urine of humans exposed to inorganic arsenic [J].
Aposhian, HV ;
Gurzau, ES ;
Le, XC ;
Gurzau, A ;
Healy, SM ;
Lu, XF ;
Ma, MS ;
Yip, L ;
Zakharyan, RA ;
Maiorino, RM ;
Dart, RC ;
Tircus, MG ;
Gonzalez-Ramirez, D ;
Morgan, DL ;
Avram, D ;
Aposhian, MM .
CHEMICAL RESEARCH IN TOXICOLOGY, 2000, 13 (08) :693-697
[2]   Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity [J].
Aposhian, HV .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1997, 37 :397-419
[3]   DMPS -: Arsenic Challenge Test II.: Modulation of arsenic species, including monomethylarsonous acid (MMAIII), excreted in human urine [J].
Aposhian, HV ;
Zheng, BS ;
Aposhian, MM ;
Le, XC ;
Cebrian, ME ;
Cullen, W ;
Zakharyan, RA ;
Ma, HS ;
Dart, RC ;
Cheng, Z ;
Andrewes, P ;
Yip, L ;
O'Malley, GF ;
Maiorino, RM ;
Van Voorhies, W ;
Healy, SM ;
Titcomb, A .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2000, 165 (01) :74-83
[4]   ALTERATIONS IN TISSUE LEVELS OF S-ADENOSYLMETHIONINE [J].
BALDESSARINI, RJ .
BIOCHEMICAL PHARMACOLOGY, 1966, 15 (06) :741-+
[5]   PHARMACOKINETIC COMPARISON BETWEEN FOSFOMYCIN AND OTHER PHOSPHONIC ACID-DERIVATIVES [J].
BERGAN, T .
CHEMOTHERAPY, 1990, 36 :10-18
[6]   PHOSPHATE TRANSPORT INTO BRUSH-BORDER MEMBRANE-VESICLES ISOLATED FROM RAT SMALL-INTESTINE [J].
BERNER, W ;
KINNE, R ;
MURER, H .
BIOCHEMICAL JOURNAL, 1976, 160 (03) :467-474
[7]   ROLE OF THIOLS IN THE INVITRO METHYLATION OF INORGANIC ARSENIC BY RAT-LIVER CYTOSOL [J].
BUCHET, JP ;
LAUWERYS, R .
BIOCHEMICAL PHARMACOLOGY, 1988, 37 (16) :3149-3153
[8]  
Busch AE, 1995, J AM SOC NEPHROL, V6, P1547
[9]  
Chen GQ, 1996, BLOOD, V88, P1052
[10]  
Cullen W.R., 1989, Appl. Organomet. Chem, V3, P71, DOI DOI 10.1002/aoc.590030107